-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, HiM7VaN3wT1n0p72L83qZwYuiSxAPDWNXGVjc/1faDZXrK0QlRqhT9fEFd67qWTm iRf1X9ulC5y4hjaJfKZI7A== 0001104659-07-030822.txt : 20070910 0001104659-07-030822.hdr.sgml : 20070910 20070424143543 ACCESSION NUMBER: 0001104659-07-030822 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20070424 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GENZYME CORP CENTRAL INDEX KEY: 0000732485 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 061047163 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: ONE KENDALL SQ CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 6172527500 MAIL ADDRESS: STREET 1: ONE KENDALL SQUARE CITY: CAMBRIDGE STATE: MA ZIP: 02139 CORRESP 1 filename1.htm

April 24, 2007

VIA EDGAR

Mr. Mark Brunhofer
Division of Corporation Finance
United States Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C.  20549

Re:                               Form 10-K for Fiscal Year Ended December 31, 2006 (the “10-K”) of
Genzyme Corporation (the “Company”)

Dear Mr. Brunhofer:

The Company confirms that it is in receipt of a comment letter (the “Comment Letter”) from the Staff of the Securities and Exchange Commission, dated April 19, 2007, regarding the above-referenced 10-K.  The Comment Letter requests that Company respond within 10 business days or tell the Staff when the Company will respond.  In order to fully respond to the Comment Letter, the Company believes it will need until May 10, 2007.  If, as that date draws closer, the Company believes it requires additional time, it will contact you.  The Company appreciates the Staff’s willingness to allow for the additional time.

Please call the undersigned at (617) 768-6847 if you have any questions regarding this letter.

Best regards,

 

 

 

/s/ Joanne M. Vasily-Cioffi

 

Joanne M. Vasily-Cioffi, Esq.

 

Senior Corporate Counsel

 

Genzyme Corporation

 


 -----END PRIVACY-ENHANCED MESSAGE-----